Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt flag Egypt · Delayed Price · Currency is EGP
4.320
-0.020 (-0.46%)
At close: Oct 2, 2025
-0.46%
Market Cap6.53B
Revenue (ttm)3.58B
Net Income (ttm)415.68M
Shares Out1.51B
EPS (ttm)0.27
PE Ratio15.74
Forward PE8.92
Dividend0.05 (1.23%)
Ex-Dividend DateJul 8, 2025
Volume3,794,627
Average Volume5,807,686
Open4.340
Previous Close4.340
Day's Range4.270 - 4.340
52-Week Range2.950 - 4.880
Beta0.16
RSI59.81
Earnings DateNov 13, 2025

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ... [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol RMDA
Full Company Profile

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.

Financial Statements

News

There is no news available yet.